Hypoglycemic agent for oral use of the third generation sulfonylurea group.


Gvardens 1 mg: each tablet contains:
Glimepiride USP 1 mg.
Gvardens 2 mg: each tablet contains:
Glimepiride USP 2 mg.
Gvardens 3 mg: each tablet contains:
Glimepiride USP 3 mg.
Gvardens 4 mg: each tablet contains:
Glimepiride USP 4 mg.

Diabetes mellitus type 2 (in monotherapy or as part of combination therapy with metformin or insulin).

Initial dose and dose selection:

At the beginning of treatment, 1 mg of Gvardens is prescribed once a day. If necessary, the daily dose can be gradually increased under regular monitoring of blood glucose concentrations (at intervals of 1-2 weeks) and in the following order: 1 mg – 2 mg – 3 mg – 4 mg – 6 mg of Gvardens per day. The maximum recommended daily dose is 8 mg.

The time and frequency of taking the daily dose is determined by the doctor, taking into account the patient’s lifestyle. As a rule, it is sufficient to administer the daily dose in 1 dose immediately before or during a large breakfast or, if the daily dose has not been taken, immediately before or during the first large meal.

Gvardens tablets are taken whole, without chewing, with a sufficient amount of liquid (about 0.5 cups). It is very important not to skip meals after taking Gvardens.